Optimal response to thalidomide in a patient with thalassaemia major resistant to conventional therapy
about
Evaluation of Novel Fetal Hemoglobin Inducer Drugs in Treatment of β-Hemoglobinopathy Disorders.The role of epigenetics in the induction of fetal hemoglobin: a combination therapy approach.Foetal haemoglobin inducers and thalassaemia: novel achievements.Orphan Drugs and Potential Novel Approaches for Therapies of β-Thalassemia: Current Status and Future ExpectationsErythropoiesis: insights into pathophysiology and treatments in 2017.
P2860
Optimal response to thalidomide in a patient with thalassaemia major resistant to conventional therapy
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
Optimal response to thalidomid ...... istant to conventional therapy
@ast
Optimal response to thalidomid ...... istant to conventional therapy
@en
type
label
Optimal response to thalidomid ...... istant to conventional therapy
@ast
Optimal response to thalidomid ...... istant to conventional therapy
@en
prefLabel
Optimal response to thalidomid ...... istant to conventional therapy
@ast
Optimal response to thalidomid ...... istant to conventional therapy
@en
P2093
P2860
P356
P1476
Optimal response to thalidomid ...... istant to conventional therapy
@en
P2093
Andrea Biondi
Chiara Vimercati
Giovanni Cazzaniga
Giuseppe Masera
Lorena Pozzi
Luisa Tavecchia
Marietta Capra
Nicoletta Masera
P2860
P356
10.2450/2009.0102-09
P577
2010-01-01T00:00:00Z